Literature DB >> 14505930

Antigen-specific IgA and IgG responses in calves inoculated intranasally with ovalbumin encapsulated in poly(DL-lactide-co-glycolide) microspheres.

Owen V Kavanagh1, Bernadette Earley, Margaret Murray, Colin J Foster, Brian M Adair.   

Abstract

The immunogenicity of proteins encapsulated in poly(DL-lactide-co-glycolide) (PLG) microspheres has not been investigated to any extent in large animal models. In this study, IgG and IgA responses to ovalbumin (OVA), encapsulated in microspheres was investigated following intranasal inoculation into calves. Scanning electron microscopy and flow cytometric analysis demonstrated a uniform microsphere population with a diameter of < 2.5 micrometers. Ovalbumin was released steadily from particles stored in PBS almost in a linear fashion, and after 4 weeks many particles showed cracks and fissures in their surface structure. Following intranasal inoculation of calves with different doses of encapsulated antigen, mean levels of ovalbumin-specific IgA were observed to increase steadily but significant differences in IgA levels (from the pre-inoculation level) were only observed following a second intranasal inoculation. With 0.5 and 1.0mg doses of antigen, ovalbumin-specific IgG was also detected in serum. Ovalbumin-specific IgA persisted in nasal secretions for a considerable period of time and were still detectable in four out of seven animals, 6 months after inoculation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505930     DOI: 10.1016/s0264-410x(03)00432-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Comparing the immune response to a novel intranasal nanoparticle PLGA vaccine and a commercial BPI3V vaccine in dairy calves.

Authors:  Fawad Mansoor; Bernadette Earley; Joseph P Cassidy; Bryan Markey; Simon Doherty; Michael D Welsh
Journal:  BMC Vet Res       Date:  2015-08-21       Impact factor: 2.741

Review 2.  Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.

Authors:  Shujing Wang; Huiqin Liu; Xinyi Zhang; Feng Qian
Journal:  Protein Cell       Date:  2015-05-06       Impact factor: 14.870

3.  Protective immunity against toxoplasmosis in mice induced by single-dose immunization with rSAG1/2 protein released from poly(lactide-co-glycolide) microparticles.

Authors:  Shu-Chun Chuang; Yao-Chi Chung; Chung-Da Yang
Journal:  Parasite       Date:  2017-02-01       Impact factor: 3.000

Review 4.  Applications of Nanovaccines for Disease Prevention in Cattle.

Authors:  Teresia W Maina; Elizabeth A Grego; Paola M Boggiatto; Randy E Sacco; Balaji Narasimhan; Jodi L McGill
Journal:  Front Bioeng Biotechnol       Date:  2020-12-11

5.  Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles.

Authors:  Kai Zhao; Gang Chen; Xing-Ming Shi; Ting-Ting Gao; Wei Li; Yan Zhao; Feng-Qiang Zhang; Jin Wu; Xianlan Cui; Yun-Feng Wang
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

Review 6.  Nanoparticle vaccines against respiratory viruses.

Authors:  Brian M Adair
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2009 Jul-Aug

7.  Protective Immunity against Vibrio harveyi in Grouper Induced by Single Vaccination with Poly (Lactide-co-glycolide) Microparticles Releasing Pleurocidin Peptide and Recombinant Glyceraldehyde-3-phosphate Dehydrogenase.

Authors:  Shang-Pin Liu; Shu-Chun Chuang; Chung-Da Yang
Journal:  Vaccines (Basel)       Date:  2020-01-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.